Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
Under the PMBJP, till 30.06.2022, 8742 PMBJKs have been opened across the country including Government Hospitals and Government premises.
Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies
New Director supports NASDAQ rule on diversity
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
Subscribe To Our Newsletter & Stay Updated
